# Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications

> **NCT05119829** · — · UNKNOWN · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 80 (estimated)

## Conditions studied

- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05119829
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-02-01
- **Primary completion:** 2023-01
- **Final completion:** 2023-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05119829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05119829, "Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05119829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*